Literature DB >> 29649621

Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.

Briana R De Miranda1, Emily M Rocha1, Qing Bai1, Amina El Ayadi1, David Hinkle1, Edward A Burton2, J Timothy Greenamyre3.   

Abstract

DJ-1 is a redox-sensitive protein with several putative functions important in mitochondrial physiology, protein transcription, proteasome regulation, and chaperone activity. High levels of DJ-1 immunoreactivity are reported in astrocytes surrounding pathology associated with idiopathic Parkinson's disease, possibly reflecting the glial response to oxidative damage. Previous studies showed that astrocytic over-expression of DJ-1 in vitro prevented oxidative stress and mitochondrial dysfunction in primary neurons. Based on these observations, we developed a pseudotyped lentiviral gene transfer vector with specific tropism for CNS astrocytes in vivo to overexpress human DJ-1 protein in astroglial cells. Following vector delivery to the substantia nigra and striatum of adult Lewis rats, the DJ-1 transgene was expressed robustly and specifically within astrocytes. There was no observable transgene expression in neurons or other glial cell types. Three weeks after vector infusion, animals were exposed to rotenone to induce Parkinson's disease-like pathology, including loss of dopaminergic neurons, accumulation of endogenous α-synuclein, and neuroinflammation. Animals over-expressing hDJ-1 in astrocytes were protected from rotenone-induced neurodegeneration, and displayed a marked reduction in neuronal oxidative stress and microglial activation. In addition, α-synuclein accumulation and phosphorylation were decreased within substantia nigra dopaminergic neurons in DJ-1-transduced animals, and expression of LAMP-2A, a marker of chaperone mediated autophagy, was increased. Together, these data indicate that astrocyte-specific overexpression of hDJ-1 protects neighboring neurons against multiple pathologic features of Parkinson's disease and provides the first direct evidence in vivo of a cell non-autonomous neuroprotective function of astroglial DJ-1.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocyte; Chaperone-mediated autophagy; DJ-1; Gene therapy; Neuroinflammation; Oxidative stress; Parkinson's disease; Rotenone

Mesh:

Substances:

Year:  2018        PMID: 29649621      PMCID: PMC5943150          DOI: 10.1016/j.nbd.2018.04.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  130 in total

1.  Park7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsis.

Authors:  Wenjun Liu; Hailong Wu; Lili Chen; Yankai Wen; Xiaoni Kong; Wei-Qiang Gao
Journal:  Cell Res       Date:  2015-05-29       Impact factor: 25.617

2.  Microglial activation and chronic neurodegeneration.

Authors:  Melinda E Lull; Michelle L Block
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

3.  Overexpression of DJ-1 protects against C2-ceramide-induced neuronal death through activation of the PI3K/AKT pathway and inhibition of autophagy.

Authors:  Jenny Jaramillo-Gómez; Andrea Niño; Humberto Arboleda; Gonzalo Arboleda
Journal:  Neurosci Lett       Date:  2015-07-26       Impact factor: 3.046

4.  Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.

Authors:  S Kobayashi; S O Ogren; B J Hoffer; L Olson
Journal:  Exp Neurol       Date:  1998-12       Impact factor: 5.330

5.  A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

Authors: 
Journal:  Clin Neuropharmacol       Date:  2008 May-Jun       Impact factor: 1.592

6.  Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.

Authors:  Lena F Burbulla; Pingping Song; Joseph R Mazzulli; Enrico Zampese; Yvette C Wong; Sohee Jeon; David P Santos; Judith Blanz; Carolin D Obermaier; Chelsee Strojny; Jeffrey N Savas; Evangelos Kiskinis; Xiaoxi Zhuang; Rejko Krüger; D James Surmeier; Dimitri Krainc
Journal:  Science       Date:  2017-09-07       Impact factor: 47.728

7.  Rotenone could activate microglia through NFκB associated pathway.

Authors:  Yu-he Yuan; Jian-dong Sun; Miao-miao Wu; Jin-feng Hu; Shan-ying Peng; Nai-Hong Chen
Journal:  Neurochem Res       Date:  2013-05-07       Impact factor: 3.996

8.  DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.

Authors:  Ravindran Kumaran; Ann Kingsbury; Ian Coulter; Tammaryn Lashley; David Williams; Rohan de Silva; David Mann; Tamas Revesz; Andrew Lees; Rina Bandopadhyay
Journal:  Neurobiol Dis       Date:  2007-07-18       Impact factor: 5.996

9.  A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake.

Authors:  Beryl Luk; Mohinuddin Mohammed; Fang Liu; Frank J S Lee
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

10.  DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.

Authors:  L Zondler; L Miller-Fleming; M Repici; S Gonçalves; S Tenreiro; R Rosado-Ramos; C Betzer; K R Straatman; P H Jensen; F Giorgini; T F Outeiro
Journal:  Cell Death Dis       Date:  2014-07-24       Impact factor: 8.469

View more
  27 in total

1.  Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration.

Authors:  Alevtina Zharikov; Qing Bai; Briana R De Miranda; Amber Van Laar; J Timothy Greenamyre; Edward A Burton
Journal:  Neurobiol Dis       Date:  2019-01-15       Impact factor: 5.996

2.  Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease.

Authors:  Briana R De Miranda; J Timothy Greenamyre
Journal:  Environ Sci Process Impacts       Date:  2020-01-30       Impact factor: 4.238

3.  Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson's Disease Incidence.

Authors:  Briana R De Miranda; Marco Fazzari; Emily M Rocha; Sandra Castro; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

4.  Dysregulation in the Brain Protein Profile of Zebrafish Lacking the Parkinson's Disease-Related Protein DJ-1.

Authors:  Amanda J Edson; Helena A Hushagen; Ann Kristin Frøyset; Inga Elda; Essa A Khan; Antonio Di Stefano; Kari E Fladmark
Journal:  Mol Neurobiol       Date:  2019-06-19       Impact factor: 5.590

5.  Taste Impairments in a Parkinson's Disease Model Featuring Intranasal Rotenone Administration in Mice.

Authors:  Dong Xu Yin; Hiroki Toyoda; Kazunori Nozaki; Keitaro Satoh; Ayano Katagiri; Kazunori Adachi; Takafumi Kato; Hajime Sato
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

6.  Altered prefrontal neurochemistry in the DJ-1 knockout mouse model of Parkinson's disease: complementary semi-quantitative analyses with in vivo magnetic resonance spectroscopy and MALDI-MSI.

Authors:  Wei Chen; Huihui Liu; Sijie Liu; Yan Kang; Zongxiu Nie; Hao Lei
Journal:  Anal Bioanal Chem       Date:  2022-10-08       Impact factor: 4.478

Review 7.  Astrocytes in Neurodegeneration: Inspiration From Genetics.

Authors:  Jingxuan Huang; Chunyu Li; Huifang Shang
Journal:  Front Neurosci       Date:  2022-06-24       Impact factor: 5.152

Review 8.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

9.  The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.

Authors:  Briana R De Miranda; Sandra L Castro; Emily M Rocha; Christopher R Bodle; Katrina E Johnson; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2021-02-23       Impact factor: 5.996

10.  VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration.

Authors:  Silas A Buck; Briana R De Miranda; Ryan W Logan; Kenneth N Fish; J Timothy Greenamyre; Zachary Freyberg
Journal:  J Neurosci       Date:  2021-04-23       Impact factor: 6.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.